Company intelligence / Profile preview
Hoba Therapeutics
Copenhagen, Denmarkhobatherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hoba Therapeutics develops novel biopharmaceuticals targeting chronic neuropathic pain and sensorineural hearing loss. Their lead candidate HB‑086 targets the peripheral nervous system with a non-opioid mechanism to reverse neuropathic pain; it will enter Phase 1 clinical trials for CIPN. The second program, HB‑097, aims to prevent or reverse ototoxic sensorineural hearing loss by protecting or regenerating nerve cells. Both programs are based on proprietary neurotrophic protein technology derived from endogenous human proteins meteorin and cometin. The company recently raised €23 million in Series A funding to advance these candidates toward clinical development.
- Therapeutic areas
- Neurology
- Modalities
- Recombinant proteins (therapeutic proteins based on neurotrophic factors meteorin and cometin)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Hoba Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hoba Therapeutics.